Pentoxifylline (NCS HealthCare of KY, Inc dba Vangard Labs)
Welcome to the PulseAid listing for the Pentoxifylline drug offered from NCS HealthCare of KY, Inc dba Vangard Labs. This Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | NCS HealthCare of KY, Inc dba Vangard Labs |
NON-PROPRIETARY NAME: | Pentoxifylline |
SUBSTANCE NAME: | PENTOXIFYLLINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-09-21 |
END MARKETING DATE: | 0000-00-00 |
Pentoxifylline HUMAN PRESCRIPTION DRUG Details:
Item Description | Pentoxifylline from NCS HealthCare of KY, Inc dba Vangard Labs |
LABELER NAME: | NCS HealthCare of KY, Inc dba Vangard Labs |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(mg/1) |
START MARKETING DATE: | 2009-09-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0615-4523_e71a3614-e3ae-4979-b6d9-1556c2ca2161 |
PRODUCT NDC: | 0615-4523 |
APPLICATION NUMBER: | ANDA074425 |
Other PENTOXIFYLLINE Pharmaceutical Manufacturers / Labelers: